Role of nitric oxide and prostaglandins in the long-term control of renal function

Hypertension

Volumn 32, Issue 1, 1998, Pages 33-38

  González, Juan D ^a   Llinás, Maria T ^a   Nava, Eduardo ^a   Ghiadoni, Lorenzo ^b   Salazar, F Javier ^a  

^a UNIVERSITY OF MURCIA   (Spain)

^b NONE

Author keywords

Nitric oxide; Plasma renin activity; Prostaglandins; Sodium; Vasoconstriction

Indexed keywords

MECLOFENAMIC ACID; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE INHIBITOR; RENIN; SODIUM ION;

ANIMAL EXPERIMENT; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DOG; FEMALE; GLOMERULUS FILTRATION RATE; HYPERTENSION; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; KIDNEY VASCULAR RESISTANCE; NATRIURESIS; NONHUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; SODIUM URINE LEVEL; VASOCONSTRICTION;

EID: 0345404357     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.32.1.33     Document Type: Article

References (25)

1. Romero JC, Lahera V, Ruilope LM. Role of nitric oxide on the intrarenal regulation of nephron function and its relevance to hypertension. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis and Management. New York, NY: Raven Press, Ltd; 1995:1385-1404.
2. Navar LG, Inscho EW, Majid SA, Imig JD, Hamson-Bernard LM, Mitchell KD. Paracrine regulation of the renal microcirculation. Physiol Rev. 1996;76:425-536.
3. Raij L, Baylis C. Glomerular actions of nitric oxide. Kidney Int. 1995; 48:20-32.
4. Romero JC, Knox FG. Mechanisms underlying pressure-related natriuresis: the role of the renin-angiotensin and prostaglandins systems: state of the art lecture. Hypertension. 1988;11:724-738.
5. Salazar FJ, Llinás MT, González JD, Quesada T, Pinilla JM. Role of prostaglandins and nitric oxide in mediating renal response to volume expansion. Am J Physiol. 1995;268:R1442-R1448.
6. Llinás MT, González JD, Nava E, Salazar FJ. Role of angiotensin II in the renal effects induced by nitric oxide and prostaglandin synthesis inhibition. J Am Soc Nephrol. 1997;8:543-550.
7. Lüscher TF, Dohi Y, Tschudi M. Endothelium-dependent regulation of resistance arteries: alterations with aging and hypertension. J Cardiovasc Pharmacol. 1992;19(suppl 5):S34-S42.
8. Houston MC. Nonsteroidal anti-inflammatory drugs and antihypertensives. Am J Med. 1991;90(suppl 5A):S42-S47.
9. Wittmann U, Nafz B, Ehmke H, Kirchheim R, Persson PB. Frequency domain of renal autoregulation in the conscious dog. Am J Physiol. 1995;269:F317-F322.
10. Pinilla JM, Alberola A, González JD, Quesada T, Salazar FJ. Role of prostaglandins on the renal effects of angiotensin and interstitial pressure during volume expansion. Am J Physiol. 1993;265:R1469-R1474.
11. Ruilope LM, Robles RG, Paya C, Rodicio JL, Romero JC. Effects of long-term treatment with indomethacin on renal function. Hypertension. 1986;8:677-684.
12. Clive DM, Stoff JS. Renal syndromes associated with nonsteroidal anti-inflammatory drugs. N Engl J Med. 1984;310:563-572.
13. Manning RD, Hu L. Nitric oxide regulates renal hemodynamics and urinary sodium excretion in dogs. Hypertension. 1994;23:619-625.
14. Granger JP, Novak J, Schnackenberg C, Williams S, Reinhart GA. Role of renal nerves in mediating the hypertensive effects of nitric oxide synthesis inhibition. Hypertension. 1996;27:613-618.
15. Bachmann S, Bosse HM, Mundel P. Topography of nitric oxide synthesis by localizing constitutive NO synthases in mammalian kidney. Am J Physiol. 1995;268:F885-F898.
16. Salazar FJ, Pinilla JM, López F, Romero JC, Quesada T. Renal effects of prolonged synthesis inhibition of endothelium-derived nitric oxide. Hypertension. 1992;20:113-117.
17. Salazar FJ, Alberola A, Pinilla JM, Romero JC, Quesada T. Salt-induced increase in arterial pressure during nitric oxide synthesis inhibition. Hypertension. 1993;22:49-55.
18. Takase H, Moreau P, Küng CF, Nava E, Lüscher TF. Antihypertensive therapy prevents endothelial dysfunction in chronic nitric oxide deficiency: effects of verapamil and trandolapril. Hypertension. 1996;27:25-31.
19. Pollock DM, Polakowski JS, Divish BJ, Opgenorth TJ. Angiotensin blockade reverses hypertension during long-term nitric oxide synthase inhibition. Hypertension. 1993;21:660-666.
20. Navarro-Cid J, Maeso R, Rodrigo E, Muñoz-Garcia R, Ruilope LM, Lahera V, Cachofeiro V. Renal and vascular consequences of the chronic nitric oxide synthase inhibition: effects of antihypertensive drugs. Am J Hypertens. 1996;9:1077-1083.
21. Yamada SS, Sassaki AL, Fujihara CK, Malheiros DM, De Nucci G, Zatz R. Effect of salt intake and inhibitor dose on arterial hypertension and renal injury induced by chronic nitric oxide blockade. Hypertension. 1996;27:1165-1172.
22. Zanchi A, Schaad NC, Osterheld MC, Grouzmann E, Nussberger J, Brunner HR, Waeber B. Effects of chronic NO synthase inhibition on renin-angiotensin system and sympathetic nervous system. Am J Physiol. 1995;268:H2267-H2273.
23. Llinás MT, González JD, Salazar FJ. Interactions between angiotensin and nitric oxide in the renal response to volume expansion. Am J Physiol. 1995;269:R504-R510.
24. Olsen ME, Hall JE, Montani JP, Cornell JE. Protection of preglomerular vessels from angiotensin II vasoconstriction by renal prostaglandins. J Hypertens. 1985;3(suppl 3):S255-S258.
25. Schlondorff D. Renal complications of nonsteroidal anti-inflammatory drugs. Kidney Int. 1993;44:643-653.